GARD conducts multidisciplinary research for the early diagnosis and prediction of dementia.
By integrating clinical, neuroimaging, genomic, and biospecimen data, GARD develops precision medicine-based prediction models and healthcare service platforms.
Advancing early dementia prediction through clinical, neuroimaging, and biomarker data.
Building an integrated research platform through standardized cohort data management.
Translating research outcomes into healthcare services through collaborative networks.